Predicting complete response: Is there a role for non-operative management of rectal cancer? Journal Article


Authors: Jonathan Yang, T.; Goodman, K. A.
Article Title: Predicting complete response: Is there a role for non-operative management of rectal cancer?
Abstract: Pre-operative chemoradiotherapy followed by a total mesorectal excision (TME) is the standard of care for patients with locally advanced (stage II or III) rectal cancer. Approximately 20% of patients may achieve a pathologic complete response after chemoradiation therapy (CRT), which has been shown to be associated with better oncologic outcomes. Whether surgery can be avoided in this population is an area of active investigation. Recent studies demonstrated feasibility and safety of non-operative management in patients with clinical complete response (cCR) after chemoradiotherapy. In this article, we set out to review the current data on non-operative management and to identify areas requiring further investigation, including improvement in imaging for reassessment after CRT and identifying the optimal time frame for restaging. As the field moves forward with non-operative management in select patients with rectal cancer, there continues to be a need to better understand the prognostic factors and biomarkers that may more accurately characterize patients who are qualified for this "wait-and-see" approach and thereby avoid overtreatment, potentially leading to improvements in long-term quality of life. © Journal of Gastrointestinal Oncology.
Keywords: treatment response; fluorouracil; advanced cancer; patient selection; disease free survival; cancer staging; positron emission tomography; antineoplastic agent; cancer grading; diagnostic accuracy; quality of life; computer assisted tomography; carcinoembryonic antigen; diagnostic imaging; folinic acid; long term care; oxaliplatin; rectum cancer; chemoradiotherapy; rectal cancer; cancer prognosis; human; article; non-operative management; chemoradiation therapy (crt)
Journal Title: Journal of Gastrointestinal Oncology
Volume: 6
Issue: 2
ISSN: 2078-6891
Publisher: Pioneer Bioscience Publishing Company  
Date Published: 2015-08-01
Start Page: 241
End Page: 246
Language: English
DOI: 10.3978/j.issn.2078-6891.2014.110
PROVIDER: scopus
PMCID: PMC4311100
PUBMED: 25830042
DOI/URL:
Notes: Article -- Export Date: 6 December 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karyn A Goodman
    257 Goodman
  2. Jonathan T Yang
    166 Yang